164 related articles for article (PubMed ID: 2862821)
1. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
[TBL] [Abstract][Full Text] [Related]
2. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin infusion on VIP-induced transport changes in the human jejunum.
Krejs GJ
Peptides; 1984; 5(2):271-6. PubMed ID: 6147815
[TBL] [Abstract][Full Text] [Related]
4. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
5. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
[No Abstract] [Full Text] [Related]
6. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
Santangelo WC; Dueno MI; Krejs GJ
Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
[No Abstract] [Full Text] [Related]
7. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
8. Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel.
Dueno MI; Bai JC; Santangelo WC; Krejs GJ
Dig Dis Sci; 1987 Oct; 32(10):1092-6. PubMed ID: 2888608
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
Juby LD; Burke DA; Axon AT
Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
[TBL] [Abstract][Full Text] [Related]
10. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome.
Davis GR; Camp RC; Raskin P; Krejs GJ
Gastroenterology; 1980 Feb; 78(2):346-9. PubMed ID: 7350058
[TBL] [Abstract][Full Text] [Related]
11. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
Maton PN; O'Dorisio TM; Howe BA; McArthur KE; Howard JM; Cherner JA; Malarkey TB; Collen MJ; Gardner JD; Jensen RT
N Engl J Med; 1985 Jan; 312(1):17-21. PubMed ID: 2856888
[No Abstract] [Full Text] [Related]
12. Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?
Kraenzlin ME; Ch'ng JC; Wood SM; Bloom SR
Lancet; 1983 Dec 24-31; 2(8365-66):1501. PubMed ID: 6140590
[No Abstract] [Full Text] [Related]
13. Somatostatin and analogues in the treatment of VIPoma.
O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
[No Abstract] [Full Text] [Related]
14. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
Kane MG; O'Dorisio TM; Krejs GJ
N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
[TBL] [Abstract][Full Text] [Related]
15. Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo.
Wu ZC; O'Dorisio TM; Cataland S; Mekhjian HS; Gaginella TS
Dig Dis Sci; 1979 Aug; 24(8):625-30. PubMed ID: 223821
[TBL] [Abstract][Full Text] [Related]
16. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
Clements D; Elias E
Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
[No Abstract] [Full Text] [Related]
17. Pancreatic cholera syndrome due to a vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology.
Rood RP; DeLellis RA; Dayal Y; Donowitz M
Gastroenterology; 1988 Mar; 94(3):813-8. PubMed ID: 2828145
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
Reubi JC; Heitz PU; Gyr K
Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
[No Abstract] [Full Text] [Related]
19. Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea.
Edwards C; Cann PA; Read NW; Holdsworth CD
Gut; 1986 May; 27(5):581-6. PubMed ID: 2870957
[TBL] [Abstract][Full Text] [Related]
20. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
